"
According to Invion's most recent annual report, the company wrote down $10.7 million through 2012 and 2013, with a 2013 year-end balance of negative $116.5 million. "Very successful biotech companies don't show black ink," Glass said. "And as we progress, we'll generate more and more red ink until someone steps in."" - delaware online
They will write down that amount+ again this year. So yes, the biggest question mark is "until someone steps in", I hope the AGM will provide a clue as to interest.
" According to Invion's most recent annual report, the company...
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $9.05K | 3.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 7290841 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 9809899 | 16 |
View Market Depth
| Last trade - 13.48pm 09/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |